Evidence map›Paper›PMID 28392989›Full record

ArticlePeerJ2017

Sevoflurane postconditioning protects the myocardium against ischemia/reperfusion injury via activation of the JAK2-STAT3 pathway.

Jianjiang Wu, Jin Yu, Peng Xie, Yiliyaer Maimaitili, Jiang Wang, Long Yang, Haiping Ma, Xing Zhang, Yining Yang, Hong Zheng

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Apigenin Alleviates Myocardial Reperfusion Injury in Rats by Downregulating miR-15b.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  17. An Update on the Multifaceted Roles of STAT3 in the Heart.Frontiers in cardiovascular medicine · 2019
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jianjiang WuDepartment of Anesthesiology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi, Xinjiang , China.
Jin YuDepartment of Anesthesiology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi, Xinjiang , China.
Peng XieDepartment of Anesthesiology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi, Xinjiang , China.
Yiliyaer MaimaitiliDepartment of Anesthesiology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi, Xinjiang , China.
Jiang WangDepartment of Anesthesiology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi, Xinjiang , China.
Long YangDepartment of Anesthesiology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi, Xinjiang , China.
Haiping MaDepartment of Anesthesiology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi, Xinjiang , China.
Xing ZhangDepartment of Aerospace Medicine, Fourth Military Medical University , Xi'an, Shanxi , China.
Yining YangDepartment of Cardiology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi, Xinjiang , China.
Hong ZhengDepartment of Anesthesiology, The First Affiliated Hospital of Xinjiang Medical University , Urumqi, Xinjiang , China.
Xinjiang Medical University · CNFirst Affiliated Hospital of Xinjiang Medical University · CNAir Force Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSevoflurane postconditioning (S-post) has similar cardioprotective effects as ischemic preconditioning. However, the underlying mechanism of S-post has not been fully elucidated. Janus kinase signaling transduction/transcription activator (JAK2-STAT3) plays an important role in cardioprotection. The purpose of this study was to determine whether the cardioprotective effects of S-post are associated with activation of the JAK2-STAT3 signal pathway.

methodsAn adult male Sprague-Dawley (SD) rat model of myocardial ischemia/reperfusion (I/R) injury was established using the Langendorff isolated heart perfusion apparatus. At the beginning of reperfusion, 2.4% sevoflurane alone or in combination with AG490 (a JAK2 selective inhibitor) was used as a postconditioning treatment. The cardiac function indicators, myocardial infarct size, lactic dehydrogenase (LDH) release, mitochondrial ultrastructure, mitochondrial reactive oxygen species (ROS) generation rates, ATP content, protein expression of p-JAK, p-STAT3, Bcl-2 and Bax were measured.

resultsCompared with the I/R group, S-post significantly increased the expression of p-JAK, p-STAT3 and Bcl-2 and reduced the protein expression of Bax, which markedly decreased the myocardial infarction areas, improved the cardiac function indicators and the mitochondrial ultrastructure, decreased the mitochondrial ROS and increased the ATP content. However, the cardioprotective effects of S-post were abolished by treatment with a JAK2 selective inhibitor (

conclusionThis study demonstrates that the cardioprotective effects of S-post are associated with the activation of JAK2-STAT3. The mechanism may be related to an increased expression of p-JAK2 and p-STAT3 after S-post, which reduced mitochondrial ROS generation and increased mitochondrial ATP content, thereby reducing apoptosis and myocardial infarct size.

Indexed as

ApoptosisIschemia–reperfusion injuryJAK2–STAT3 pathwayReactive oxygen speciesSevoflurane postconditioning

Identifiers

PMID28392989
PMCPMC5382923
OpenAlexW2604703113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.